(Q35768296)

English

Oral 1-O-octadecyl-2-O-benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in mice

scientific article published on 9 November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Oral 1-O-octadecyl-2-O-benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Ectromelia virus

object named as

ectromelia virus

1 reference

based on heuristic

inferred from title

Karl Y Hostetler

object named as

Karl Y Hostetler

1

0 references

author name string

James R Beadle

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Julissa Trahan

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Kathy A Aldern

4

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Gelita Owens

5

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Jill Schriewer

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Lora Melman

7

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

R Mark Buller

8

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

publication date

9 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Antiviral Research

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

73

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

212-218

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Activities of alkoxyalkyl esters of cidofovir (CDV), cyclic CDV, and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against orthopoxviruses in cell monolayers and in organotypic cultures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1859865

12 July 2018

Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1859865

12 July 2018

Comparison of the antiviral activities of alkoxyalkyl and alkyl esters of cidofovir against human and murine cytomegalovirus replication in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1859865

12 July 2018

Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1859865

12 July 2018

Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1859865

12 July 2018

Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1859865

12 July 2018

Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1859865

12 July 2018

Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1859865

25 September 2018

Increased antiviral activity of 1-O-hexadecyloxypropyl-[2-(14)C]cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1859865

25 September 2018

Measurement of the respiratory volumes of laboratory animals

1 reference

https://pubmed.ncbi.nlm.nih.gov/17123638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.ANTIVIRAL.2006.10.009

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35768296&oldid=1883550025"